AOL Search

Web Results

• FDA Approves Vivus's Fast-Acting Viagra Rival

  Apr 27, 2012 ... NEW YORK, April 27 (Reuters) - Men with erectile dysfunction may not have to plan for sex as far in advance anymore after Vivus Inc won U.S. ...

  www.huffingtonpost.com/2012/04/27/fda-approves-vivus-viagra-rival...

• Qnexa Proponents Ask U.S. Experts To Back The Obesity Drug

  Feb 22, 2012 ... SILVER SPRING, Md., Feb 22 (Reuters) - Proponents of a new obesity medication from Vivus Inc told U.S. reviewers on Wednesday that the ...

  www.huffingtonpost.com/2012/02/22/qnexa-obesity-drug_n_1294465.ht...

• FDA Panel Backs Qnexa, Previously Rejected Obesity Pill

  Feb 22, 2012... raising hopes that the drug from Vivus Inc. could become the first new anti- obesity medication to reach the U.S. market in more than a decade ...

  www.huffingtonpost.com/2012/02/23/fda-panel-backs-qnexa-pre_n_129...

• Diet Pill Qnexa's Safety Still Questioned By FDA

  Feb 17, 2012 ... WASHINGTON -- Federal health officials say they still have safety concerns about an experimental diet pill from drugmaker Vivus Inc., as the ...

  www.huffingtonpost.com/2012/02/17/diet-pill-qnexas-safety-s_n_128...

• Finish Line, RIM, Vivus are market movers

  Mar 30, 2012 ... Vivus Inc., up $1.08 at $22.36. A Brean Murray Carret & Co. analyst upgraded the biopharmaceutical company's stock to a "Buy" rating from ...

  www.huffingtonpost.com/huff-wires/20120330/us-wall-street-stocks/

• Sears, Kohl's, Vivus are market movers

  Feb 23, 2012 ... Vivus Inc., up $8.18 at $18.73. A panel of Food and Drug Administration advisers gave a strong endorsement to the drugmaker's potential ...

  www.huffingtonpost.com/huff-wires/20120223/us-wall-street-stocks/

• Lorcaserin: FDA Advisers Recommend Approving Weight Loss Drug

  May 10, 2012 ... Earlier this year, rival Vivus Inc. won a surprising endorsement from an FDA panel for its diet drug, Qnexa. That move raised expectations for ...

  www.huffingtonpost.com/2012/05/11/lorcaserin-weight-loss-drug-fda...

• Lorcaserin Obesity Pill Works, But FDA Questions Heart Safety

  May 8, 2012 ... NEW YORK — Vivus Inc.'s potential weight loss drug Qnexa will likely draw scrutiny over nervous system and psychiatric side effects from a ...

  www.huffingtonpost.com/2012/05/08/lorcaserin-obesity-pill-heart-s...

• Heart Risks Of Obesity Drugs: U.S. Ponders Safety Trials ...

  Mar 26, 2012 ... The agency is set to decide in mid-April on Vivus Inc's Qnexa. Outside advisers are due to review Arena Pharmaceuticals Inc's lorcaserin in ...

  www.huffingtonpost.com/2012/03/26/heart-risk-obesity-drug_n_13802...

• 3 Weight Loss Drugs Make Second Bid For Approval

  Feb 24, 2012 ... This week a panel of advisers to the FDA overwhelmingly recommended approval for Qnexa, on the condition Vivus Inc. conduct a follow-up ...

  www.huffingtonpost.com/2012/02/27/weight-loss-drugs-qnexa-contrav...